Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation

摘要

Purpose To assess the incidence, clinical features and predictive risk factors of subretinal fibrosis after treatment of active myopic choroidal neovascularisation (mCNV) with anti-vascular endothelial growth factor (VEGF).